Table of Contents Author Guidelines Submit a Manuscript
TheScientificWorldJOURNAL
Volume 10, Pages 2403-2413
http://dx.doi.org/10.1100/tsw.2010.229
Mini-Review Article

Montelukast: More than a Cysteinyl Leukotriene Receptor Antagonist?

1Department of Internal Medicine, Faculty of Health Sciences, University of Pretoria, South Africa
2Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
3Medical Research Council Unit for Inflammation and Immunity, Department of Immunology, University of Pretoria, and Tshwane Academic Division of the National Health Laboratory Service, Pretoria, South Africa

Received 6 August 2010; Revised 11 November 2010; Accepted 15 November 2010

Academic Editor: Charles N. Serhan

Copyright © 2010 Gregory R. Tintinger et al.

Citations to this Article [51 citations]

The following is the list of published articles that have cited the current article.

  • Carolina Alvarez, María M. Amaral, Cecilia Langellotti, and Mónica Vermeulen, “Leukotriene C4 prevents the complete maturation of murine dendritic cells and modifies interleukin-12/interleukin-23 balance,” Immunology, vol. 134, no. 2, pp. 185–197, 2011. View at Publisher · View at Google Scholar
  • Rachel G. Moebus, and Joseph K. Han, “Immunomodulatory treatments for aspirin exacerbated respiratory disease,” American Journal of Rhinology & Allergy, vol. 26, no. 2, pp. 134–140, 2012. View at Publisher · View at Google Scholar
  • Hiroichi Nagai, “Recent research and developmental strategy of anti-asthma drugs,” Pharmacology & Therapeutics, vol. 133, no. 1, pp. 70–78, 2012. View at Publisher · View at Google Scholar
  • A. Scaife, D. Miller, D. Spiteri-Cornish, S.W. Turner, G.S. Devereux, and G.M. Walsh, “Inhibitory effects of Montelukast on mediator release by nasal epithelial cells from asthmatic subjects with or without allergic rhinitis,” Respiratory Medicine, 2013. View at Publisher · View at Google Scholar
  • Stefano Fogli, Fabio Stefanelli, Tommaso Neri, Claudio Bardelli, Angela Amoruso, Sandra Brunelleschi, Alessandro Celi, and Maria Cristina Breschi, “Montelukast prevents microparticle-induced inflammatory and functional alterations in human bronchial smooth muscle cells,” Pharmacological Research, 2013. View at Publisher · View at Google Scholar
  • Xia-Yan Zhang, Wei-Ping Zhang, Er-Qing Wei, Xiao-Rong Wang, Dong-Min Xu, Shu-Ying Yu, Qiao-Juan Shi, Li-Hui Zhang, Lu Chen, San-Hua Fang, and Yun-Bi Lu, “HAMI 3379, a CysLT2 receptor antagonist, attenuates ischemia-like neuronal injury by inhibiting microglial activation,” Journal of Pharmacology and Experimental Therapeutics, vol. 346, no. 2, pp. 328–341, 2013. View at Publisher · View at Google Scholar
  • Astrid Stefanie Kahnt, Florian Rörsch, Olaf Diehl, Bettina Hofmann, Christoph Lehmann, Svenja Dorothea Steinbrink, Carlo Angioni, Gerd Geisslinger, Sabine Grösch, Dieter Steinhilber, and Thorsten Jürgen Maier, “Cysteinyl leukotriene-receptor-1 antagonists interfere with PGE2 synthesis by inhibiting mPGES-1 activity,” Biochemical Pharmacology, vol. 86, no. 2, pp. 286–296, 2013. View at Publisher · View at Google Scholar
  • Rakesh kumar Singh, Ruchi Tandon, Sunanda Ghosh Dastidar, and Abhijit Ray, “A Review on Leukotrienes and Their Receptors with Reference to Asthma,” Journal of Asthma, pp. 1–32, 2013. View at Publisher · View at Google Scholar
  • Raimondo D’Ambrosio, Clifford L Eastman, Cinzia Fattore, and Emilio Perucca, “Novel frontiers in epilepsy treatments: preventing epileptogenesis by targeting inflammation,” Expert Review of Neurotherapeutics, vol. 13, no. 6, pp. 615–625, 2013. View at Publisher · View at Google Scholar
  • Akio Niimi, “Cough, asthma, and cysteinyl-leukotrienes,” Pulmonary Pharmacology & Therapeutics, 2013. View at Publisher · View at Google Scholar
  • Stefano Fogli, Fabio Stefanelli, Alma Martelli, Simona Daniele, Laura Testai, Vincenzo Calderone, Letizia Trincavelli, Claudia Martini, and Maria Cristina Breschi, “Protective effect of high-dose montelukast on salbutamol-induced homologous desensitisation in airway smooth muscle,” Pulmonary Pharmacology & Therapeutics, 2013. View at Publisher · View at Google Scholar
  • Gökhan Koca, Salih S. Gültekin, Ünsal Han, Serdar Kuru, Koray Demirel, and Meliha Korkmaz, “The efficacy of montelukast as a protective agent against 131I-induced salivary gland damage in rats,” Nuclear Medicine Communications, vol. 34, no. 5, pp. 507–517, 2013. View at Publisher · View at Google Scholar
  • G. R. Tintinger, R. Anderson, and C. Feldman, “Pharmacological approaches to regulate neutrophil activity,” Seminars in Immunopathology, vol. 35, no. 4, pp. 395–409, 2013. View at Publisher · View at Google Scholar
  • Ihab T. Abdel-Raheem, and Naglaa F. Khedr, “Renoprotective effects of montelukast, a cysteinyl leukotriene receptor antagonist, against methotrexate-induced kidney damage in rats,” Naunyn-Schmiedeberg's Archives of Pharmacology, 2013. View at Publisher · View at Google Scholar
  • Ozge Yilmaz, Derya Altintas, Carmen Rondon, Cemal Cingi, and Fatih Oghan, “Effectiveness of Montelukast In Pediatric Patients With Allergic Rhinitis,” International Journal of Pediatric Otorhinolaryngology, 2013. View at Publisher · View at Google Scholar
  • W.J. Randerath, “Aspirin-exacerbated respiratory disease,” Deutsche Medizinische Wochenschrift, vol. 138, no. 11, pp. 541–546, 2013. View at Publisher · View at Google Scholar
  • Annette J. Theron, Helen C. Steel, Gregory R. Tintinger, Charles Feldman, and Ronald Anderson, “Can the anti-inflammatory activities of beta 2-agonists be harnessed in the clinical setting?,” Drug Design Development and Therapy, vol. 7, pp. 1387–1398, 2013. View at Publisher · View at Google Scholar
  • J.-S. Park, S.-J. Kang, M.-k. Seo, I. Jou, H. G. Woo, and S. M. Park, “Role of cysteinyl leukotriene signaling in a mouse model of noise-induced cochlear injury,” Proceedings of the National Academy of Sciences, vol. 111, no. 27, pp. 9911–9916, 2014. View at Publisher · View at Google Scholar
  • Brijeshkumar Patel, Nilesh Gupta, and Fakhrul Ahsan, “Aerosolized Montelukast Polymeric Particles—An Alternative to Oral Montelukast–Alleviate Symptoms of Asthma in a Rodent Model,” Pharmaceutical Research, 2014. View at Publisher · View at Google Scholar
  • Xiao-Yan Zhang, Lu Chen, Yi Yang, Dong-Min Xu, Si-Ran Zhang, Chen-Tan Li, Wei Zheng, Shu-Ying Yu, Er-Qing Wei, and Li-Hui Zhang, “Regulation of rotenone-induced microglial activation by 5-lipoxygenase and cysteinyl leukotriene receptor 1,” Brain Research, 2014. View at Publisher · View at Google Scholar
  • Sheng-Hua Wu, Pei-Yuan Liao, Xiao-Qing Chen, Pei-Ling Yin, and Ling Dong, “Add-on therapy with montelukast in the treatment of Henoch-Schönlein purpura,” Pediatrics International, 2014. View at Publisher · View at Google Scholar
  • Uzdan Uz, Bei Chen, James N. Palmer, Cemal Cingi, and Halis Unlu, “Effects of thymoquinone and montelukast on sinonasal ciliary beat frequency,” American Journal of Rhinology & Allergy, vol. 28, no. 2, pp. 122–125, 2014. View at Publisher · View at Google Scholar
  • Roxana K. Mincheva, Vasil D. Dimitrov, Todor A. Popov, Tanya Z. Kralimarkova, Miroslava Rasheva, Zlatko Dimitrov, Denislava Nedeva, Maria Staevska, Vera Papochieva, Penka Perenovska, and Karina Bacheva, “A real - life observational pilot study to evaluate the effects of two-week treatment with montelukast in patients with chronic cough,” Cough, vol. 10, no. 1, 2014. View at Publisher · View at Google Scholar
  • Wonyong Lee, Hyeong Su Kim, and Gap Ryol Lee, “Leukotrienes induce the migration of Th17 cells,” Immunology and Cell Biology, 2014. View at Publisher · View at Google Scholar
  • Sadiman Kiykac Altinbas, Omer Lutfi Tapisiz, Sabri Cavkaytar, Gulcin Simsek, Serpil Oguztuzun, and Umit Goktolga, “Is montelukast effective in regression of endometrial implants in an experimentally induced endometriosis model in rats?,” European Journal of Obstetrics & Gynecology and Reproductive Biology, 2014. View at Publisher · View at Google Scholar
  • Johana Béné, Emeline Gantois, Marion Landouzy, Marine Auffret, Patrick Coupé, Mélanie Courouble, and Sophie Gautier, “Ecchymoses associées à la prise de montélukast : à propos d’un cas,” Thérapie, 2014. View at Publisher · View at Google Scholar
  • Rosalina Wisastra, and Frank J. Dekker, “Inflammation, cancer and oxidative lipoxygenase activity are intimately linked,” Cancers, vol. 6, no. 3, pp. 1500–1521, 2014. View at Publisher · View at Google Scholar
  • A. J. Theron, H. C. Steel, G. R. Tintinger, C. M. Gravett, R. Anderson, and C. Feldman, “Cysteinyl Leukotriene Receptor-1 Antagonists as Modulators of Innate Immune Cell Function,” Journal of Immunology Research, vol. 2014, pp. 1–16, 2014. View at Publisher · View at Google Scholar
  • Lu Chen, Yi Yang, Chen-Tan Li, Si-Ran Zhang, Wei Zheng, Er-Qing Wei, and Li-Hui Zhang, “CysLT2 receptor mediates lipopolysaccharide-induced microglial inflammation and consequent neurotoxicity in vitro,” Brain Research, 2015. View at Publisher · View at Google Scholar
  • Serdar Kuru, Kemal Kismet, Aziz M. Barlas, Salih Tuncal, Pinar Celepli, Hatice Surer, Elmas Ogus, and Ertugrul Ertas, “The effect of montelukast on liver damage in an experimental obstructive jaundice model,” Viszeralmedizin: Gastrointestinal Medicine and Surgery, vol. 31, no. 2, pp. 131–138, 2015. View at Publisher · View at Google Scholar
  • Mustafa İçer, Yilmaz Zengin, Ercan Gunduz, Recep Dursun, Hasan Mansur Durgun, Gul Turkcu, Hatice Yuksel, Mehmet Üstündağ, and Cahfer Guloglu, “Is montelukast as effective as N-acetylcysteine in hepatic injury due to acetaminophen intoxication in rats?,” Experimental and Toxicologic Pathology, 2015. View at Publisher · View at Google Scholar
  • Lukasz Dobrek, Beata Skowron, Agnieszka Baranowska, and Piotr Jan Thor, “The influence of montelukast on the autonomic nervous system activity in rats with cyclophosphamide-induced hemorrhagic cystitis,” Current Issues in Pharmacy and Medical Sciences, vol. 28, no. 3, 2015. View at Publisher · View at Google Scholar
  • Cottini Marcello, and Lombardi Carlo, ““Asthma phenotypes: the intriguing selective intervention with Montelukast”,” Asthma Research and Practice, vol. 2, no. 1, 2016. View at Publisher · View at Google Scholar
  • Corriveau Stéphanie, Blouin Simon, Burt Elyse, Rousseau Eric, and Pasquier Jean-Charles, “Antenatal montelukast treatment reduces uterine activity associated with inflammation in a pregnant rat model,” European Journal of Obstetrics & Gynecology and Reproductive Biology, 2016. View at Publisher · View at Google Scholar
  • Naim Kittana, Suhaib Hattab, Azza Ziyadeh-Isleem, Nidal Jaradat, and Abdel-Naser Zaid, “Montelukast, current indications and prospective future applications,” Expert Review of Respiratory Medicine, pp. 1–14, 2016. View at Publisher · View at Google Scholar
  • Yi-Ching Lin, Ming-Yii Huang, Min-Sheng Lee, Chong-Chao Hsieh, Hsuan-Fu Kuo, Chang-Hung Kuo, and Chih-Hsing Hung, “Effects of montelukast on M2-related cytokine and chemokine in M2 macrophages,” Journal of Microbiology, Immunology and Infection, 2016. View at Publisher · View at Google Scholar
  • Mahmoud M. Said, and Maarten C. Bosland, “The anti-inflammatory effect of montelukast, a cysteinyl leukotriene receptor-1 antagonist, against estradiol-induced nonbacterial inflammation in the rat prostate,” Naunyn-Schmiedeberg's Archives of Pharmacology, 2016. View at Publisher · View at Google Scholar
  • Hala S. Abdel Kawy, “Montelukast versus Dexamethasone Treatment in a Guinea Pig Model of Chronic Pulmonary Neutrophilic Inflammation,” COPD: Journal of Chronic Obstructive Pulmonary Disease, pp. 1–10, 2016. View at Publisher · View at Google Scholar
  • Bao-Jian Zhao, Chi Zhang, and Er-Bin Xiao, “Adipose-derived mesenchymal stem cells regulate T cell immune status in allergic rhinitis,” Chinese Journal of Tissue Engineering Research, vol. 20, no. 10, pp. 1373–1381, 2016. View at Publisher · View at Google Scholar
  • Mahboobeh H. Sadeghi, and Alyn H. Morice, “The emerging role of the eosinophil and its measurement in chronic cough,” Open Respiratory Medicine Journal, vol. 11, pp. 17–30, 2017. View at Publisher · View at Google Scholar
  • Pannaree Piromkraipak, Kant Sangpairoj, Wuttipong Tirakotai, Kulathida Chaithirayanon, Supeenun Unchern, Porntip Supavilai, Christopher Power, and Pornpun Vivithanaporn, “Cysteinyl Leukotriene Receptor Antagonists Inhibit Migration, Invasion, and Expression of MMP-2/9 in Human Glioblastoma,” Cellular and Molecular Neurobiology, 2017. View at Publisher · View at Google Scholar
  • V?ctor H Nieto Estrada, Daniel Molano Franco, Roger David Medina, Alejandro G Gonzalez Garay, Arturo J Mart?-Carvajal, and Ingrid Arevalo-RodriguezCochrane Database of Systematic Reviews, 2017. View at Publisher · View at Google Scholar
  • Byung Hwi Kim, Min Park, Hyo Jin Park, Seung Ho Lee, Sung Yoon Choi, Chun Gwon Park, Su Min Han, Chan Yeong Heo, and Young Bin Choy, “Prolonged, acute suppression of cysteinyl leukotriene to reduce capsular contracture around silicone implants,” Acta Biomaterialia, vol. 51, pp. 209–219, 2017. View at Publisher · View at Google Scholar
  • Jingli Peng, Hezheng Zhou, Guoping Kuang, Lilian Xie, Tao Tian, and Ru Liu, “The selective cysteinyl leukotriene receptor 1 (CysLT1R) antagonist montelukast regulates extracellular matrix remodeling,” Biochemical and Biophysical Research Communications, vol. 484, no. 3, pp. 474–479, 2017. View at Publisher · View at Google Scholar
  • Hannelore Bellon, Elly Vandermeulen, Carolien Mathyssen, Annelore Sacreas, Stijn E Verleden, Tobias Heigl, Hanne Vriens, Elise Lammertyn, Charles Pilette, Peter Hoet, Robin Vos, Bart M Vanaudenaerde, and Geert M Verleden, “ Interleukin-1α induced release of interleukin-8 by human bronchial epithelial cells in vitro : assessing mechanisms and possible treatment options ,” Transplant International, vol. 30, no. 4, pp. 388–397, 2017. View at Publisher · View at Google Scholar
  • Jinsong Wei, Siyuan Chen, Chengshuo Huang, Weixiong Guo, Shukai Yang, Bailin Feng, and Jiaqi Chu, “Antagonism of cysteinyl leukot-riene receptor 1 (cysLT1R) by montelukast regulates differentiation of MC3T3-E1 cells under overloaded mechanical environment,” Biochemical and Biophysical Research Communications, 2017. View at Publisher · View at Google Scholar
  • Paolo Gelosa, Francesca Colazzo, Elena Tremoli, Luigi Sironi, and Laura Castiglioni, “Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases,” Mediators of Inflammation, vol. 2017, pp. 1–15, 2017. View at Publisher · View at Google Scholar
  • Vetrivel Babu Nagarajan, and Padmaja Anil Marathe, “Effect of montelukast in experimental model of Parkinson’s disease,” Neuroscience Letters, 2018. View at Publisher · View at Google Scholar
  • Elodie Gautier-Veyret, Magnus Bäck, Claire Arnaud, Elise Belaïdi, Renaud Tamisier, Patrick Lévy, Nathalie Arnol, Marion Perrin, Jean-Louis Pépin, and Françoise Stanke-Labesque, “Cysteinyl-leukotriene pathway as a new therapeutic target for the treatment of atherosclerosis related to obstructive sleep apnea syndrome,” Pharmacological Research, 2018. View at Publisher · View at Google Scholar
  • Antonio Di Gennaro, Ana Carolina Araújo, Albert Busch, Hong Jin, Dick Wågsäter, Emina Vorkapic, Kenneth Caidahl, Per Eriksson, Bengt Samuelsson, Lars Maegdefessel, and Jesper Z. Haeggström, “Cysteinyl leukotriene receptor 1 antagonism prevents experimental abdominal aortic aneurysm,” Proceedings of the National Academy of Sciences, pp. 201717906, 2018. View at Publisher · View at Google Scholar
  • Jinsong Wei, Siyuan Chen, Chengshuo Huang, Weixiong Guo, Shukai Yang, Bailin Feng, and Jiaqi Chu, “The cysteinyl leukotriene receptor 1 (CysLT1R) antagonist montelukast suppresses matrix metalloproteinase-13 expression induced by lipopolysaccharide,” International Immunopharmacology, vol. 55, pp. 193–197, 2018. View at Publisher · View at Google Scholar